Free Trial
NYSE:RBOT

Vicarious Surgical (RBOT) Stock Price, News & Analysis

Vicarious Surgical logo
$0.54 -0.16 (-22.80%)
As of 03:20 PM Eastern

About Vicarious Surgical Stock (NYSE:RBOT)

Advanced

Key Stats

Today's Range
$0.54
$0.69
50-Day Range
$0.42
$0.99
52-Week Range
$0.27
$13.75
Volume
26,028 shs
Average Volume
74,248 shs
Market Capitalization
$3.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Reduce

Company Overview

Vicarious Surgical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
32nd Percentile Overall Score

RBOT MarketRank™: 

Vicarious Surgical scored higher than 32% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vicarious Surgical has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Vicarious Surgical has a consensus price target of $7.00, representing about 1,205.0% upside from its current price of $0.54.

  • Amount of Analyst Coverage

    Vicarious Surgical has received no research coverage in the past 90 days.

  • Read more about Vicarious Surgical's stock forecast and price target.
  • Earnings Growth

    Earnings for Vicarious Surgical are expected to grow in the coming year, from ($10.89) to ($8.50) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vicarious Surgical is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vicarious Surgical is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Vicarious Surgical has a P/B Ratio of 0.07. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Vicarious Surgical's valuation and earnings.
  • Short Interest

    There is no current short interest data available for RBOT.
  • Dividend Yield

    Vicarious Surgical does not currently pay a dividend.

  • Dividend Growth

    Vicarious Surgical does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Vicarious Surgical this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Vicarious Surgical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vicarious Surgical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    9.46% of the stock of Vicarious Surgical is held by insiders.

  • Percentage Held by Institutions

    47.27% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Vicarious Surgical's insider trading history.
Receive RBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RBOT Stock News Headlines

Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.tc pixel
Vicarious Surgical, Inc. Class A
See More Headlines

RBOT Stock Analysis - Frequently Asked Questions

Vicarious Surgical's stock was trading at $2.16 at the start of the year. Since then, RBOT stock has decreased by 75.2% and is now trading at $0.5364.

Vicarious Surgical Inc. (NYSE:RBOT) issued its quarterly earnings results on Monday, March, 9th. The company reported ($1.65) EPS for the quarter, missing the consensus estimate of ($1.37) by $0.28.

Shares of Vicarious Surgical reverse split on the morning of Thursday, June 13th 2024.The 1-30 reverse split was announced on Thursday, June 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vicarious Surgical investors own include NVIDIA (NVDA), Aktis Oncology (AKTS), Advanced Micro Devices (AMD), PayPal (PYPL), Taiwan Semiconductor Manufacturing (TSM) and SoFi Technologies (SOFI).

Company Calendar

Last Earnings
3/09/2026
Today
6/05/2026
Next Earnings (Estimated)
7/30/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:RBOT
CIK
1812173
Fax
N/A
Employees
210
Year Founded
2014

Price Target and Rating

High Price Target
$7.00
Low Price Target
$7.00
Potential Upside/Downside
+1,205.0%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($6.69)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.22 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-184.13%
Return on Assets
-112.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.75
Quick Ratio
4.75

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.89 per share
Price / Book
0.07

Miscellaneous

Outstanding Shares
7,124,000
Free Float
5,894,000
Market Cap
$3.82 million
Optionable
No Data
Beta
1.76

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:RBOT) was last updated on 6/5/2026 by MarketBeat.com Staff.
From Our Partners